Diabetes insipidus screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(4 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Diabetes insipidus}} | {{Diabetes insipidus}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{DAMI}} | ||
{{ | |||
==Overview== | ==Overview== | ||
According to the USPSTF, screening for diabetes insipidus is not recommended. | |||
==Screening== | ==Screening== | ||
According to the USPSTF, screening for diabetes insipidus is not recommended. | |||
==References== | ==References== | ||
Line 17: | Line 17: | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
Latest revision as of 14:26, 27 September 2017
Diabetes insipidus Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Diabetes insipidus screening On the Web |
American Roentgen Ray Society Images of Diabetes insipidus screening |
Risk calculators and risk factors for Diabetes insipidus screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
According to the USPSTF, screening for diabetes insipidus is not recommended.
Screening
According to the USPSTF, screening for diabetes insipidus is not recommended.